Cryoport, Inc.
NASDAQ:CYRXIntegrated Freight & Logistics
+$0.19 today
- Market cap
- $1.02B
- Beta
- 1.89
- P/E (TTM)
- 9.5
- EPS (TTM)
- $1.55
Volume 0.66M
Average 0.69M
CYRX Capital Expenditures
Cash spent on property, plant, equipment, and other long-term assets.
Cryoport, Inc.NASDAQ: CYRX
Capital Expenditures · Q1 FY2026 · quarter ended Mar 2026
Capital expenditures growth accelerates
Q1 FY2026 capital expenditures of $10.28M (cash outflow) rose 152.1% year over year, ahead of the +40.5% change in trailing-twelve-month capital expenditures. Sequentially, it rose 108.0% from the prior quarter. Over 3 fiscal years it compounded at -6.9% a year.
Context
- Capital expenditures amounted to 11.1% of revenue in FY2025, up 3.7 pp from a year earlier.
- Capital expenditures grew in size in 2 of the last 3 fiscal years.
What to watch
Whether quarterly growth of +152.1% holds above the trailing-twelve-month pace of +40.5%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Capital Expenditures history
USD · from the cash flow
- Latest · FY2025
- (19.51M) USD
- Year-over-year change
- -13.0%
| Period | Period end | Capital Expenditures | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (19.51M) | -13.0% |
| FY2024 | 2024-12-31 | (17.25M) | +61.6% |
| FY2023 | 2023-12-31 | (44.9M) | -85.6% |
| FY2022 | 2022-12-31 | (24.2M) | +3.2% |
| FY2021 | 2021-12-31 | (25.01M) | — |
Capital Expenditures vs competitors
How CYRX compares with its peers on the latest reported figures
- CYRX's LTM Mar 2026 capital expenditures of $23.86M is the smallest of the 2 companies compared; the peer median is $30.08M.
- Its year-over-year change of +40.5% is the highest of 2, against a peer median of -11.2%.
- Capital expenditures amounts to 13.0% of revenue for CYRX, versus a peer median of 4.8%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $30.08M | -11.2% | -8.6% | 4.8% | |
| LTM Mar 2026 | $23.86M | +40.5% | -6.9% | 13.0% | |
| Peer median (excluding CYRX) | $30.08M | -11.2% | -8.6% | 4.8% | |
Competitors are the stored peer set for CYRX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (275.53M) | (37.33M) | (99.59M) | (114.76M) | 78.3M |
| Depreciation & Amortization | 20.25M | 22.77M | 27.49M | 30.76M | 27.71M |
| Deferred Income Tax | 253.79M | 0 | (1.98M) | 0 | 0 |
| Stock-Based Compensation | 15.35M | 20.08M | 22.81M | 19.7M | 11.03M |
| Change in Working Capital | (6.96M) | (32.07M) | 780K | (8.61M) | (13.69M) |
| Accounts Receivables | (7.27M) | (4.14M) | 3.67M | (4.15M) | (6.53M) |
| Inventory | (5.98M) | (14.2M) | 1.51M | 3.25M | (2.19M) |
| Accounts Payables | 2.87M | (6.48M) | (2.77M) | (76K) | (3.46M) |
| Other Working Capital | 3.42M | (7.24M) | (1.64M) | (7.64M) | (1.52M) |
| Other Non-Cash Items | 1.24M | 24.7M | 49.73M | 56.58M | (111.93M) |
| Operating Cash Flow | 8.13M | (1.85M) | (757K) | (16.32M) | (8.58M) |
| Capital Expenditures | (25.01M) | (24.2M) | (44.9M) | (17.25M) | (19.51M) |
| Acquisitions (Net) | (5.54M) | (6.55M) | (7.34M) | 0 | 210.24M |
| Purchases of Investments | (482.71M) | (163.79M) | (42.68M) | (50.72M) | 0 |
| Sales of Investments | 44M | 131.86M | 129.99M | 249.12M | 59.59M |
| Other Investing Activities | (1.13M) | 910K | (5.14M) | (4.33M) | (3.07M) |
| Investing Cash Flow | (469.25M) | (59.68M) | 36.05M | 176.82M | 250.32M |
| Debt Repayment | 36.61M | (3.26M) | (25.28M) | (164.32M) | (15.04M) |
| Common Stock Issued | 527.73M | 2.05M | 1.48M | 2.79M | 3.97M |
| Common Stock Repurchased | 0 | (37.96M) | 0 | 0 | (10.01M) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 0 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | 564.34M | (39.17M) | (23.8M) | (161.53M) | (21.07M) |
| Effect of Forex Changes | (986K) | (1.8M) | (1.74M) | (18K) | (15.46M) |
| Net Change in Cash | 102.23M | (102.51M) | 9.75M | (1.06M) | 205.21M |
| Free Cash Flow | (16.88M) | (26.05M) | (45.66M) | (33.58M) | (28.09M) |
Cryoport, Inc.
NASDAQ:CYRX
Intrinsic Alpha fair value
Locked
Current Price
$20.17
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.